Moderna (MRNA) FCF Margin (2018 - 2026)
Moderna (MRNA) reported FCF Margin of 177.89% for Q1 2026, up 82859.0% year-over-year from N/an in Q1 2025, and down 235.37% quarter-over-quarter from 131.42% in Q4 2025.
Moderna (MRNA) FCF Margin (2018 - 2026) Analysis & Trends
Moderna (MRNA) has 9 years of FCF Margin data on file, last reported at 177.89% in Q1 2026.
- FCF Margin for Q1 2026 came in at 177.89%, up 82859.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 75.06% (up 2482.0% YoY), and the FY2025 annual result was 106.22%, down 1040.0% from the prior year.
- FCF Margin slipped to 177.89% in Q1 2026 per MRNA's latest filing, from 131.42% in the prior quarter.
- Over five years, FCF Margin peaked at 131.42% in Q4 2025 and troughed at 1006.48% in Q1 2025.
- A 5-year average of 213.16% and a median of 71.05% in 2023 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2024 and 2026: FCF Margin slumped 61891 bps in 2024, then surged 82859 bps in 2026.
- A 5-year view of FCF Margin shows it stood at 32.85% in 2022, then slumped by 31 bps to 22.77% in 2023, then surged by 266 bps to 83.44% in 2024, then surged by 58 bps to 131.42% in 2025, then slumped by 235 bps to 177.89% in 2026.
- Business Quant data shows MRNA's FCF Margin at 177.89% in Q1 2026, 131.42% in Q4 2025, and 93.8% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn | -177.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -177.89% |
| Dec 31, 2025 | 131.42% |
| Sep 30, 2025 | -93.80% |
| Jun 30, 2025 | -645.07% |
| Mar 31, 2025 | -1,006.48% |
| Dec 31, 2024 | 83.44% |
| Sep 30, 2024 | -67.99% |
| Jun 30, 2024 | -886.93% |
| Mar 31, 2024 | -646.71% |
| Dec 31, 2023 | 22.77% |
| Sep 30, 2023 | -89.73% |
| Jun 30, 2023 | -268.02% |
| Mar 31, 2023 | -71.05% |
| Dec 31, 2022 | 32.85% |
| Sep 30, 2022 | 11.62% |
| Jun 30, 2022 | 4.57% |
| Mar 31, 2022 | 43.37% |
| Dec 31, 2021 | 44.24% |
| Sep 30, 2021 | 63.94% |
| Jun 30, 2021 | 92.31% |